Behavioral, hyperthermic and pharmacokinetic profile of para-methoxymethamphetamine (PMMA) in rats
- PMID: 21167195
- DOI: 10.1016/j.pbb.2010.12.011
Behavioral, hyperthermic and pharmacokinetic profile of para-methoxymethamphetamine (PMMA) in rats
Abstract
Despite poisoning with the ecstasy substitute para-methoxymethamphetamine (PMMA) being typically associated with severe hyperthermia and death, behavioral and toxicological data on this drug are missing. Herein we present the behavioral profile of PMMA, its hyperthermic potency and pharmacokinetic profile in rats. The effects of PMMA 5 and 20 mg/kg on locomotion, on prepulse inhibition (PPI) of acoustic startle reaction (ASR), on body temperature under isolated and crowded conditions and on the pharmacokinetics analyzed with gas chromatography mass spectrometry (GC-MS) were evaluated. PMMA increased overall locomotion with the higher dose showing a biphasic effect. PPI was decreased dose-dependently. The hyperthermic response was present only with PMMA 20 mg/kg and was accompanied by extensive perspiration under crowded conditions. Serum levels of PMMA peaked at approximately 30 min after both treatments; on the contrary the maximum brain concentrations of PMMA at 20 mg/kg peaked approximately 1h after the administration, which was rather delayed compared to maximum after 5mg/kg dose. These data indicate that PMMA has a similar behavioral profile to stimulants and hallucinogens and that the toxicity might be increased in a crowded environment. High doses of PMMA have a gradual penetration to the brain which might lead to the delayed peak concentrations and prolonged effects of the drug.
Copyright © 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Studies on distribution of para-methoxymethamphetamine (PMMA) designer drug in rats using gas chromatography-mass spectrometry.Leg Med (Tokyo). 2009 Apr;11 Suppl 1:S429-30. doi: 10.1016/j.legalmed.2009.01.021. Epub 2009 Mar 3. Leg Med (Tokyo). 2009. PMID: 19261515
-
Studies on distribution and metabolism of para-methoxymethamphetamine (PMMA) in rats after subcutaneous administration.Toxicology. 2009 May 2;259(1-2):61-8. doi: 10.1016/j.tox.2009.02.003. Epub 2009 Feb 13. Toxicology. 2009. PMID: 19428944
-
MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.Neuropharmacology. 2005 Aug;49(2):195-207. doi: 10.1016/j.neuropharm.2005.03.002. Neuropharmacology. 2005. PMID: 15993443
-
Relationship between methamphetamine-induced behavioral activation and hyperthermia.Brain Res. 2010 Oct 21;1357:41-52. doi: 10.1016/j.brainres.2010.08.017. Epub 2010 Aug 13. Brain Res. 2010. PMID: 20709036
-
Detailed pharmacological evaluation of methoxetamine (MXE), a novel psychoactive ketamine analogue-Behavioural, pharmacokinetic and metabolic studies in the Wistar rat.Brain Res Bull. 2016 Sep;126(Pt 1):102-110. doi: 10.1016/j.brainresbull.2016.05.002. Epub 2016 May 4. Brain Res Bull. 2016. PMID: 27155360 Review.
Cited by
-
α-Ethyltryptamine: A Ratiocinatory Review of a Forgotten Antidepressant.ACS Pharmacol Transl Sci. 2023 Nov 7;6(12):1780-1789. doi: 10.1021/acsptsci.3c00139. eCollection 2023 Dec 8. ACS Pharmacol Transl Sci. 2023. PMID: 38093842 Review.
-
Acute pharmacological profile of 2C-B-Fly-NBOMe in male Wistar rats-pharmacokinetics, effects on behaviour and thermoregulation.Front Pharmacol. 2023 Mar 9;14:1120419. doi: 10.3389/fphar.2023.1120419. eCollection 2023. Front Pharmacol. 2023. PMID: 36969854 Free PMC article.
-
Worsening of the Toxic Effects of (±)Cis-4,4'-DMAR Following Its Co-Administration with (±)Trans-4,4'-DMAR: Neuro-Behavioural, Physiological, Immunohistochemical and Metabolic Studies in Mice.Int J Mol Sci. 2021 Aug 16;22(16):8771. doi: 10.3390/ijms22168771. Int J Mol Sci. 2021. PMID: 34445476 Free PMC article.
-
Acute DOB and PMA Administration Impairs Motor and Sensorimotor Responses in Mice and Causes Hallucinogenic Effects in Adult Zebrafish.Brain Sci. 2020 Aug 24;10(9):586. doi: 10.3390/brainsci10090586. Brain Sci. 2020. PMID: 32847111 Free PMC article.
-
Evaluation of SYA16263 as a new potential antipsychotic agent without catalepsy.Pharmacol Biochem Behav. 2019 Apr;179:55-62. doi: 10.1016/j.pbb.2019.02.003. Epub 2019 Feb 12. Pharmacol Biochem Behav. 2019. PMID: 30768942 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
